• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Harvard Global Health Institute

    院校EST. 2011
    848论文总数
    5.2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(848)

    年份
    起
    –
    止
    排序
    1Molecular Mechanisms of Cold Stress-Induced Energy Stress, Cholesterol Metabolic Disorders, and Apoptosis in Pangasianodon Hypophthalmus
    Dongjie Wang,Min Li, Min Liao, Yao Tian,Qing Wu,Shaolin Xie,Wei Luo,Jixing Zou, Jun Shi,Zongjun Du

    Energy metabolism, cholesterol metabolism, and apoptosis are key physiological responses to cold stress in fish. However, the molecular mechanisms underlying these processes and their interactions remain insufficiently understood, particularly regarding their molecular interactions. In this study, we integrated physiological, histological, metabolomic, and transcriptomic approaches to reveal the molecular responses of the cold-sensitive Pangasianodon hypophthalmus (13.52 +/- 1.54 g) to programmed cooling (25 degrees C, 20 degrees C, 15 degrees C). Our results demonstrate that cold stress induces energy stress, cholesterol metabolism disorder, and apoptosis in P. hypophthalmus. Specifically, it manifests as increased serum antioxidant activity, decreased cholesterol levels, tissue damage in the gills, liver, and muscle accompanied by elevated apoptotic signals, ultrastructural damage to hepatic mitochondria, and a significant reduction in mitochondrial membrane potential. Integrated metabolomic and transcriptomic analysis identified AMPK, PPAR, PI3K/AKT/mTOR, cholesterol metabolism, primary bile acid biosynthesis, bile secretion, and intrinsic mitochondrial apoptosis pathways as key pathways of energy metabolism, cholesterol metabolism, and apoptosis under cold stress. Inhibition of AMPK and PPAR signaling pathways, along with disrupted cholesterol metabolism, represents a major factor contributing to cold stress intolerance in P. hypophthalmus. Inhibition of cholesterol synthesis during cold stress, likely through suppression of the hmgcr, was central to cholesterol metabolic disturbances. Under cold stress, concurrent inhibition of PI3K/ AKT/mTOR, cholesterol metabolism, bile acid biosynthesis, and bile secretion pathways reshaped energy metabolism to accommodate increased energy demands. When the AMPK pathway is inhibited, p53 may also function to suppress biosynthetic processes, thereby maintaining a specific metabolic state under cold stress. The results of qPCR and Western blot further support the reliability of our conclusions. In summary, these findings clarify the regulatory mechanisms and interactions among energy metabolism, cholesterol metabolism, and apoptosis in P. hypophthalmus under cold stress, providing a basis for enhancing fish resilience to cold stress challenges.

    2026AQUACULTURE(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Safety and Effects of Anti-Obesity Medications on Weight Loss, Cardiometabolic, and Psychological Outcomes in People Living with Overweight or Obesity: a Systematic Review and Meta-Analysis
    Leiling Liu, Zhiqi Li, Wenrui Ye, Pu Peng, Yurong Wang, Luqing Wan, Jiangnan Li, Mei Zhang, Yihua Wang, Runqi Liu,Danyan Xu,Jingjing Zhang

    Background Overweight and obesity pose serious health challenges for individuals and societies. This study aims to facilitate personalised treatment of obesity by summarising recent research on weight-loss pharmacotherapies, with a focus on their effects on weight reduction, cardiometabolic health, psychological outcomes, and adverse events. Methods This systematic review and meta-analysis included searches of Web of Science, PubMed, and Cochrane Central Register of Controlled Trials from inception to June 8, 2024. Randomised controlled trials evaluating weight-loss pharmacotherapies approved by the Food and Drug Administration (FDA) or European Medicines Agency (EMA) for treating overweight or obesity were included. Primary outcomes included changes in body weight, cardiometabolic indicators, psychological outcomes, and adverse events. Summary data was extracted from published reports. Random-effects meta-analyses were used to calculate weighted mean differences (WMDs), risk ratios (RRs), and 95% confidence intervals (CI). The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system was used to assess the certainty of evidence for each pooled analysis. PROSPERO registration: CRD42024547905. Findings A total of 154 randomised controlled trials (n = 112,515 participants) were included. Tirzepatide had the greatest weight-loss effect (WMD -11.69, 95% CI -19.22 to -4.15; P = 0.0024; I-2 = 100.0%; moderate certainty), followed by semaglutide (-8.48, -12.68 to -4.27; P < 0.0001; I-2 = 100.0%; moderate certainty). Tirzepatide had the strongest antihypertensive effect on both systolic (WMD -5.74, -9.00 to -2.48; P = 0.0006; I-2 = 99.8%; moderate certainty) and diastolic blood pressure (WMD -2.91, -4.97 to -0.85; P = 0.0056; I-2 = 99.8%; moderate certainty) and best reduced triglycerides (WMD -0.77, -0.85 to -0.69; P < 0.0001; I-2 = 3.2%; high certainty), fasting glucose (WMD -3.06, -5.53 to -0.59; P = 0.015; I-2 = 100.0%; moderate certainty), insulin (WMD -4.91, -8.15 to -1.68; P = 0.0029; I-2 = 97.0%; moderate certainty), and glycated haemoglobin levels (WMD -1.27, -1.82 to -0.73; P < 0.0001; I-2 = 100.0%; moderate certainty). Semaglutide (RR 0.83, 0.74-0.92; P < 0.0001; I-2 = 0.0%; high certainty) and liraglutide (0.87, 0.79-0.96; P = 0.0059; I-2 = 0.0%; high certainty) reduced the risk of major adverse cardiovascular events (MACEs). However, all three medications were associated with adverse gastrointestinal effects. Naltrexone/bupropion increased the risk of elevated blood pressure (RR 1.72, 1.04-2.85; P = 0.036; I-2 = 0.0%; high certainty). Topiramate increased depression risk (RR 1.62, 1.14 to 2.30; P = 0.0077; I-2 = 0.0%; high certainty), and phentermine/topiramate raised concerns about anxiety (RR 1.91, 1.09 to 3.35; P = 0.025; I-2 = 29.5%; high certainty), sleep disorders (RR 1.55, 1.24-1.93; P < 0.0001; I-2 = 0.0%; high certainty), and irritability (RR 3.31, 1.69-6.47; P < 0.0001; I-2 = 0.0%; high certainty). No medication increased the risk of serious adverse events. Interpretation For weight reduction, tirzepatide is the top choice, followed by semaglutide. Considering cardiometabolic risk factors, tirzepatide shows the best blood pressure- and glucose-lowering benefits, while semaglutide and liraglutide reduce the risk of MACEs. Naltrexone/bupropion carries a risk of increased blood pressure. Phentermine/topiramate should be used with caution due to its higher risk of psychological side effects. Despite limitations related to study heterogeneity, these fi ndings provide valuable insights for weight management strategies across diverse individuals.

    2025ECLINICALMEDICINE(2025)引用:20
    引用
    AI阅读
    加入学术空间
    3Bacterial-induced Duox-ROS Regulates the Imd Immune Pathway in the Gut by Modulating the Peritrophic Matrix.
    Shuai Bai,Zhichao Yao,Zhaohui Cai,Qiongke Ma, Qiongyu Guo, Ping Zhang,Qi Zhou, Jian Gu, Siying Liu,Bruno Lemaitre,Xiaoxue Li,Hongyu Zhang

    The Duox-reactive oxygen species (ROS) system and the immune deficiency (Imd) pathway play a major role in insect gut immunity. However, their interaction to accomplish an effective immune response is still unclear. Here, we show that Duox regulates the peritrophic matrix (PM) and further affects the Imd immune response to pathogens in Bactrocera dorsalis. This regulation requires a nuanced ROS balance: low H2O2 increases PM permeability, while higher H2O2 damages the PM during infection. Importantly, we found that gut commensal bacteria ensured proper Duox-dependent ROS production and PM stability, thus preventing Imd pathway overactivation in response to pathogens. We conclude that gut commensal bacteria-induced Duox-ROS is crucial for maintaining PM structural homeostasis, and the PM, in turn, regulates Imd pathway activation and protects intestinal epithelial cells. Thus, our study reveals a crosstalk between the PM barrier and Imd-mediated antibacterial function to ensure host defense in the gut.

    2025Cell reports(2025)引用:16
    引用
    AI阅读
    加入学术空间
    4Impact of Scaling Up Breastfeeding on Reducing the Global Burden of Non-Communicable Diseases in Mothers and Children: a Population-Based Modelling Analysis for 132 Low-Income and Middle-Income Countries.
    Divya Bhandari, Wafaie W Fawzi,Mandana Arabi,Goodarz Danaei

    BACKGROUND:Growing evidence suggests breastfeeding offers long-term protective effects against non-communicable diseases (NCDs) later in life in mothers and their offspring. These benefits could be substantial at the population level but have not yet been rigorously quantified. We aimed to estimate the population-level effect of scaling up exclusive breastfeeding on long-term NCD burden in mothers and their offspring in 132 low-income and middle-income countries (LMICs). METHODS:In this population-based modelling analysis, we developed mathematical simulation models based on the population impact fraction estimator and leveraging available effect estimates and global input data. We conducted umbrella reviews to obtain pooled effect estimates from high-quality meta-analyses, with quality assessed using AMSTAR-2. Input data included cause-specific mortality (Global Burden of Diseases, Injuries, and Risk Factors Study), diabetes and hypertension prevalence (NCD Risk Factor Collaboration), baseline exclusive breastfeeding coverage (WHO-UNICEF), and demographics (UN Population Division). We quantified delayed cause-specific NCD deaths, averted diabetes and hypertension cases, and years of life gained (YLG) across four exclusive breastfeeding coverage scenarios. All future benefits were discounted (3% rate). FINDINGS:Scaling up exclusive breastfeeding coverage to 90% in 132 LMICs could delay 0·17% of NCD deaths across the two generations, equivalent to 72 300 delayed NCD deaths annually, yielding 1·04 million YLG. It substantially reduced type 2 diabetes prevalence by 1·29% (10 million cases averted across the lifespan of the cohort) and moderately reduced hypertension prevalence by 0·17% (3·8 million averted cases). The maternal generation constituted 42% of delayed deaths, 23% of averted diabetes cases, and approximately half of the total YLG. Regionally, southeast Asia, east Asia, and Oceania followed by south Asia had the largest absolute benefits due to population size; however, after adjusting for cohort and population size, sub-Saharan Africa and north Africa and the Middle East showed the largest benefits per million intervened mothers. Most delayed deaths were from ischaemic heart disease (43%) and stroke (33%), with cancer accounting for 18%. INTERPRETATION:Scaling up exclusive breastfeeding coverage could lead to benefits in reducing NCDs, complementing its established benefits for child mortality and early childhood development. FUNDING:Nutrition International.

    2025The Lancet Global health(2025)引用:4
    引用
    AI阅读
    加入学术空间
    5Systematic Review and Meta-Analysis of Antigen Rapid Diagnostic Tests to Detect Zaire Ebolavirus
    Devy M. Emperador,Cassandra Kelly-Cirino,Daniel G. Bausch,Isabella Eckerle

    We conducted a systematic review and meta-analysis of studies and reports comparing the performance of antigen rapid diagnostic tests (Ag RDT) for diagnosing Ebola disease (EVD). We searched PubMed, EMBASE, and Web of Science for diagnostic studies published between 1976 and 2023, evaluating them with QUADAS-2. Using a bivariate random-effects model, we estimated the pooled sensitivity and specificity of Ag RDTs. Of 64 eligible full studies and reports, 16 met the inclusion criteria. Pooled sensitivity and specificity were 82.1% (95%CI: 75.2 - 88.0) and 97.0% (95%CI: 95.1-98.2), respectively. We conducted subgroup analysis on 4 Ag RDTs, 3 RT-PCR tests, and 4 sample types, showing varied performance. The high specificity and positive predictive value of Ag RDTs support their use to "rule-in" patients with EVD. However, high-sensitivity RDTs suitable for field settings and capable of detecting multiple ebolavirus species are needed.

    2025DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE(2025)引用:4
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 848 篇论文

    合作机构(100)

    哈佛大学合作论文 47
    洛桑联邦理工学院合作论文 40
    帝国理工学院合作论文 25
    卢旺天主教大学合作论文 24
    日内瓦大学合作论文 19
    洛桑大学合作论文 18
    牛津大学合作论文 18
    哥本哈根大学合作论文 17
    法国国家科学研究中心合作论文 16
    索瓦巴女王纪念研究所合作论文 15

    机构统计